Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-04-30
1982-12-21
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 9, 128659, A61K 4900, A61K 4300
Patent
active
043649203
ABSTRACT:
Diagnostic reagents comprising a chelating agent and stannous tin which are suitable for conversion to radiopharmaceuticals by the addition of a radionuclide, such as suitable forms of technetium 99m, are stabilized against oxidation and/or hydrolysis by the addition to said complex of ascorbic acid, erythorbic acid, pharmaceutically acceptable inorganic salts thereof or mixtures thereof.
REFERENCES:
patent: 3725295 (1973-04-01), Eckelman et al.
patent: 3735001 (1973-05-01), McRae et al.
patent: 3740418 (1973-06-01), Rajamani et al.
patent: 3787565 (1974-01-01), Nouel et al.
patent: 3902849 (1975-09-01), Barak et al.
Epstein William H.
Gould George M.
Medi--Physics, Inc.
Nucker Christine M.
Saxe Jon S.
LandOfFree
Stable diagnostic reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable diagnostic reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable diagnostic reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-405893